FreMon Scientific, Inc.
Overview
The global market for freezer-to-vein blood management solutions is growing at 5-6% annually with more than than 600M units of stem cells, plasma and other blood components being frozen or refrigerated each year. FreMon Scientific has developed a thawing and warming device that performs with greater speed, safety, accuracy, and portability than any other device on the market, and is submitting the device for FDA approval in December, 2017.